Megavoltage 2D topographic imaging: An attractive alternative to megavoltage CT for the localization of breast cancer patients treated with TomoDirect

被引:0
|
作者
Meyer, Philippe [1 ]
Le Pennec, Fabien [1 ]
Hui, Susanta K. [2 ]
Dehaynin, Nicolas [1 ]
Jarnet, Delphine [1 ]
Gantier, Matthieu [1 ]
Niederst, Claudine [1 ]
Mazzara, Christophe [1 ]
Baudrier, Etienne [3 ]
Noblet, Vincent [3 ]
机构
[1] Paul Strauss Ctr, Dept Med Phys, Strasbourg, France
[2] City Hope Natl Med Ctr, Dept Radiat Oncol, Belle Chasse, LA USA
[3] ICube, UMR 7357, Strasbourg, France
来源
PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS | 2017年 / 39卷
关键词
Topographic megavoltage 2D imaging; TomoTherapy treatments; Breast cancer; HELICAL TOMOTHERAPY; STATIC TOMOTHERAPY; RADIOTHERAPY; RISK;
D O I
10.1016/j.ejmp.2017.06.015
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: To show the usefulness of topographic 2D megavoltage images (MV2D) for the localization of breast cancer patients treated with TomoDirect (TD), a radiotherapy treatment technique with fixed-angle beams performed on a TomoTherapy system. Methods: A method was developed to quickly localize breast cancer patients treated with TD by registering the MV2D images produced before a TD treatment with reference images reconstructed from a kilo-voltage CT simulation scanner and by using the projection of the beam-eye-view TD treatment field. Dose and image quality measurements were performed to determine the optimal parameters for acquiring MV2D images. A TD treatment was simulated on a chest phantom equipped with a breast attachment. MVCT and MV2D images were performed for 7 different shifted positions of the phantom and registered by 10 different operators with the simulation kilovoltage CT images. Results: Compared to MVCT, MV2D imaging reduces the dose by a factor of up to 45 and the acquisition time by a factor of up to 49. Comparing the registration shift values obtained for the phantom images obtained with MVCT in the coarse mode to those obtained with MV2D, the mean difference is 1.0 +/- 1.1 mm, -1.1 mm +/- 1.1, and -0.1 +/- 2.2 mm, respectively, in the lateral, longitudinal, and vertical directions. Conclusions: With dual advantages (very fast imaging and a potentially reduced dose to the heart and contralateral organs), MV2D topographic images may be an attractive alternative to MVCT for the localization of breast cancer patients treated with TomoDirect. (C) 2017 Associazione Italiana di Fisica Medica. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:33 / 38
页数:6
相关论文
共 50 条
  • [21] SGRT impact on 2D transit in-vivo dosimetry for breast cancer patients
    Anson, C.
    Jornet, N.
    Gallego, P.
    Perez-Alija, J.
    Latorre-Musoll, A.
    Garcia, N.
    Vivancos, H.
    Barcelo, M.
    Ruiz, A.
    Leo, F.
    Carrasco, P.
    RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S726 - S726
  • [22] Difference in the Set-up Margin between 2D Conventional and 3D CT Based Planning in Patients with Early Breast Cancer
    Jo, Sunmi
    Chun, Mison
    Kim, Mi-Hwa
    Oh, Young-Taek
    Kang, Seunghee
    Noh, O. Kyu
    RADIATION ONCOLOGY JOURNAL, 2010, 28 (03): : 177 - 183
  • [23] A mm-Wave 2D Ultra-Wideband Imaging Radar for Breast Cancer Detection
    Moscato, Stefano
    Matrone, Giulia
    Pasian, Marco
    Mazzanti, Andrea
    Bozzi, Maurizio
    Perregrini, Luca
    Svelto, Francesco
    Magenes, Giovanni
    Arcioni, Paolo
    Summers, Paul
    INTERNATIONAL JOURNAL OF ANTENNAS AND PROPAGATION, 2013, 2013
  • [24] THE COMPARISON OF 2D/2D-KV AND CBCT TECHNIQUES DURING BREAST CANCER PATIENTS RADIOTHERAPY.
    Szczepanik, K.
    RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S589 - S589
  • [25] Evaluation of doses on a 2D map of the rectal wall for patients treated with IMRT for prostate cancer
    Munbodh, R.
    Jackson, A.
    Bauer, J.
    Yang, J.
    Pham, H.
    Xiong, J.
    Zelefsky, M. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S76 - S76
  • [26] Autofluorescence imaging captures heterogeneous drug response differences between 2D and 3D breast cancer cultures
    Cannon, T. M.
    Shah, A. T.
    Skala, M. C.
    BIOMEDICAL OPTICS EXPRESS, 2017, 8 (03): : 1911 - 1925
  • [27] A COMPARISON OF TOXICITIES IN CERVICAL CANCER PATIENTS TREATED USING 2D VERSUS 3D BRACHYTHERAPY PLANNING
    Abdullah, T.
    Chitoni, M.
    Reed, N.
    Harrand, R.
    Graham, K.
    Sadozye, A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (09) : 911 - 911
  • [28] Evaluation of 2D and 3D radiomics features extracted from CT images of oesophageal cancer patients
    Piazzese, C.
    Whybra, P.
    Carrington, R.
    Crosby, T.
    Staffurth, J.
    Foley, K.
    Spezi, E.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S1180 - S1181
  • [29] Vaginal dose point reporting in cervical cancer patients treated with combined 2D/3D external beam radiotherapy and 2D/3D brachytherapy
    Westerveld, Henrike
    Poetter, Richard
    Berger, Daniel
    Dankulchai, Pittaya
    Doerr, Wolfgang
    Sora, Mircea-Constantin
    Poetter-Lang, Sarah
    Kirisits, Christian
    RADIOTHERAPY AND ONCOLOGY, 2013, 107 (01) : 99 - 105
  • [30] Comparison of the Effect of Simple and Complex Acquisition Trajectories on the 2D SPR and 3D Voxelized Differences for Dedicated Breast CT Imaging
    Shah, Jainil P.
    Mann, Steve D.
    McKinley, Randolph L.
    Tornai, Martin P.
    MEDICAL IMAGING 2014: PHYSICS OF MEDICAL IMAGING, 2014, 9033